Cover Image

A Risk-Factor Model for Antineoplastic Drug-Induced Serious Adverse Events in Cancer Inpatients: A Retrospective Study Based on the Global Trigger Tool and Machine Learning

The objective of this study was to apply a machine learning method to evaluate the risk factors associated with serious adverse events (SAEs) and predict the occurrence of SAEs in cancer inpatients using antineoplastic drugs. A retrospective review of the medical records of 499 patients diagnosed wi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ni Zhang (Author), Ling-Yun Pan (Author), Wan-Yi Chen (Author), Huan-Huan Ji (Author), Gui-Qin Peng (Author), Zong-Wei Tang (Author), Hui-Lai Wang (Author), Yun-Tao Jia (Author), Jun Gong (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients
by: Lunara Teles Silva, et al.
Published: (2020)

Characterization of adverse drug events identified by trigger in Brazilian pediatric inpatients
by: Lunara Teles Silva, et al.
Published: (2020)

Cardiovascular adverse events associated with oral antineoplastic therapy
by: Jacqueline Mota da Silva, et al.

Predicting Adverse Drug Events in Chinese Pediatric Inpatients With the Associated Risk Factors: A Machine Learning Study
by: Ze Yu, et al.
Published: (2021)

Establishing a trigger tool based on global trigger tools to identify adverse drug events in obstetric inpatients in China
by: Shan Wu, et al.
Published: (2024)

Serious Neurological Adverse Events of Ceftriaxone
by: Clémence Lacroix, et al.
Published: (2021)

The Brazilian Portuguese version of the Pediatric Trigger Toolkit is applicable to measure the occurrence of adverse drug events in Brazilian pediatric inpatients
by: Lunara Teles Silva, et al.
Published: (2019)

The Brazilian Portuguese version of the Pediatric Trigger Toolkit is applicable to measure the occurrence of adverse drug events in Brazilian pediatric inpatients
by: Lunara Teles Silva, et al.
Published: (2019)

Identification of small cell lung cancer patients who are at risk of developing common serious adverse event groups with machine learning
by: Linda Wanika, et al.
Published: (2023)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
by: Colleen M. Kingsbury, et al.
Published: (2024)

Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units
by: Palamini Marie, et al.
Published: (2020)

Medication errors in a children's inpatient antineoplastic chemotherapy facility
by: Victoria E. Barrios-López, et al.
Published: (2022)

Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring
by: Ling Shu, et al.
Published: (2024)

Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
by: William Queiroz Guimarães Wiegandt Ceglio, et al.
Published: (2022)

Clinical drug interactions between voriconazole and 38 other drugs: a retrospective analysis of adverse events
by: Ben-Nian Huo, et al.
Published: (2024)

HE USE OF TRIGGER TOOLSIN THE IDENTIFICATION OF ADVERSE DRUG EVENTS
by: Cleni Veroneze, et al.
Published: (2017)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
by: Ming-Tao Wen, et al.
Published: (2024)

Serious Cardiovascular Adverse Events Reported with Intravenous Sedatives: A Retrospective Analysis of the MedWatch Adverse Event Reporting System
by: Matthew S. Duprey, et al.
Published: (2019)

First vaccination after birth: serious adverse events of Bacillus Calmette-Guérin (BCG) in real-world
by: Jinmiao Lu, et al.
Published: (2022)

Effect of an inpatient nursing risk early warning and control system in Shanghai: A retrospective study of adverse events
by: Qian Wu, et al.
Published: (2015)

Incidence and management of the main serious adverse events reported after COVID‐19 vaccination
by: Teresa Padilla‐Flores, et al.
Published: (2024)

Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the FDA Adverse Event Reporting System database
by: Dongxuan Li, et al.
Published: (2024)

Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self‐controlled case series analysis
by: Sherrie L. Aspinall, et al.
Published: (2020)

Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis.
by: Sauman Singh-Phulgenda, et al.
Published: (2021)

Hypersensitivity Reactions in Serious Adverse Events Reported for Paracetamol in the EudraVigilance Database, 2007-2018
by: Iwona Popiołek, et al.
Published: (2019)

Serious Adverse Events Reporting in Phase III Randomized Clinical Trials of Colorectal Cancer Treatments: A Systematic Analysis
by: Yanhong Yao, et al.
Published: (2021)

Introduction of antineoplastic drug NSC631570 in an inpatient and outpatient setting: Comparative evaluation of biological effects
by: Mariia Rudyk, et al.
Published: (2016)

Machine learning approach to identify adverse events in scientific biomedical literature
by: Sonja Wewering, et al.
Published: (2022)

Unpacking adverse events and associations post COVID-19 vaccination: a deep dive into vaccine adverse event reporting system data
by: Yiming Li, et al.
Published: (2024)

Trackers for Adverse Events in Child Mental Health: descriptive analysis using the global trigger tool
by: Sandna Larissa Freitas dos Santos, et al.
Published: (2023)

Active monitoring of antifungal adverse events in hospitalized patients based on Global Trigger Tool method
by: Xiao Meng, et al.
Published: (2024)

Naloxone as a trigger to identify opioid-related adverse events in pediatric intensive care units
by: Haline Ogata, et al.
Published: (2019)

Fact-Finding Survey and Exploration of Preventive Drugs for Antineoplastic Drug-Induced Oral Mucositis Using the Japanese Adverse Drug Event Report Database
by: Hajime Matsuo, et al.
Published: (2024)

Joint association of sleep duration and physical activity with cognitive performance among Chinese adults: an analysis of nationally representative survey data
by: Huan Tao, et al.
Published: (2023)

A comparative analysis on serious adverse events reported for COVID-19 vaccines in adolescents and young adults
by: Beniamino Cappelletti-Montano, et al.
Published: (2023)

Establishment of a pediatric trigger tool based on Global Trigger Tool to identify adverse drug events of children: experience in a Chinese hospital
by: Yi Liu, et al.
Published: (2020)

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
by: Pernille Kähler Byskov, et al.
Published: (2024)

A systematic review of gastritis as an immune-related adverse event in clinical interventions
by: Fei Su, et al.
Published: (2024)

Adverse event profiles of dipeptidyl peptidase-4 inhibitors: data mining of the public version of the FDA adverse event reporting system
by: Jing Huang, et al.
Published: (2020)

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023
by: Yihan Yang, et al.
Published: (2024)